GOING CONCERN	6 Months Ended
GOING CONCERN	Apr. 30, 2016
GOING CONCERN [Abstract]
GOING CONCERN	NOTE 3 – GOING CONCERN At April 30, 2016, the Company had accumulated deficit of $321,232 and no current source of revenues. The Company has suffered recurring losses from operations. The Company expects to finance its operations primarily through the contribution from its president. There is no assurance that the Company will be able to obtain such additional capital. Additionally, no assurance can be given that any such financing, if obtained, will be adequate to meet the Company’s ultimate capital needs and to support its growth. If adequate capital cannot be obtained on a timely basis and on satisfactory terms, the Company’s operations would be materially negatively impacted. As a result of the above discussed conditions, there exists substantial doubt about the Company’s ability to continue as a going concern. The Company’s financial statements are presented on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments relating to the recoverability of the recorded assets or the classification of liabilities that may be necessary should it be determined that the Company is unable to continue as a going concern.

AMERICAN GENE ENGINEER CORP 10-Q